Posted: July 22, 2022
The Horseracing Integrity and Safety Authority has released for public comment its “Prohibited Substances Technical Document” in advance of the Jan. 1, 2023, launch of the HISA Anti-Doping and Medication Control Program.
In a letter, Adolpho Birch III, chair of the Anti-Doping and Medication Control Standing Committee, briefly outlined the document, which includes screening limits and detection times. The letter notes that the law authorizing HISA mandates use of the International Federation of Horseracing Authorities international screening limits for urine and plasma as baselines.
“The HISA Technical Document is being made available for the purpose of generating feedback and comment from the industry and other stakeholders,” Birch said. “While the HISA Act requires that IFHA baselines be observed, it also permits deviations if recommended by the Anti-Doping and Medication Control Standing Committee and approved by the (HISA) Enforcement Agency. Therefore, if you wish to suggest a change, please provide your rationale and any supporting scientific evidence so that it can be properly considered.”
Anyone wishing to comment can do so at the HISA website.